Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, ...

By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation methodology (Amp-Seq) with Illumina's proven and highly scalable sequencing technology, the partnership ...

As the Distinguished William S. C. Chang Endowed Chair in the UC San Diego Jacobs School of Engineering’s Department of ...

After hours: September 26 at 7:19 PM EDT ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

In the rapidly evolving field of genomics, a new class of non-coding RNAs has captured the attention of researchers worldwide - circular RNAs (circRNAs). Unlike their linear counterparts, circRNAs are ...

Refurbished DNA Sequencing Platform market – Comprehensive Study with focus on key drivers, trends, methodology, landscape & comparative Research Nidhi Bhawsar HTF Market Intelligence Consulting ...

As you read this, a white box the size of a refrigerator is hurtling through space at 17,500 miles per hour (28,000 kph), ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

Short-read (Illumina) 16S-EZ - For genus/species identification of bacteria and archaea - Targeted sequencing of 16S rRNA gene (V3 & V4 regions) - Short-read (Illumina) Full Length 16S - For ...